Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sparteine oxidation polymorphism: a family study.

K Brøsen, S V Otton, L F Gram

    British Journal of Clinical Pharmacology
    |June 1, 1986
    PubMed
    Summary

    Poor sparteine metabolism is an autosomal recessive trait. This genetic characteristic influences drug metabolism, with poor metabolizers (PM) exhibiting significantly higher sparteine/dehydrosparteine ratios in urine compared to extensive metabolizers (EM).

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PHARMACOKINETICS AND CLINICAL RESPONSE TO TRICYCLIC ANTIDEPRESSANTS.

    Acta psychiatrica Scandinavica·2017
    Same author

    Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans.

    Clinical pharmacology and therapeutics·2017
    Same author

    Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study.

    Clinical pharmacology and therapeutics·2017
    Same author

    Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2017
    Same author

    Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.

    Clinical pharmacology and therapeutics·2016
    Same author

    Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study.

    Journal of thrombosis and haemostasis : JTH·2015

    Area of Science:

    • Pharmacogenetics
    • Drug Metabolism
    • Human Genetics

    Background:

    • Sparteine oxidation exhibits polymorphic behavior in humans.
    • Understanding genetic variations in drug metabolism is crucial for personalized medicine.

    Purpose of the Study:

    • To investigate the inheritance pattern of sparteine polymorphic oxidation.
    • To phenotype individuals based on sparteine metabolic ratios (MR).

    Main Methods:

    • Phenotyping using the metabolic ratio (MR) of sparteine to dehydrosparteines in 12-hour urine samples.
    • Analysis of 35 parents and 29 siblings from 20 unrelated poor metabolizer (PM) probands.
    • Pedigree analysis to determine inheritance patterns.

    Main Results:

    • A bimodal distribution of MR was observed, classifying individuals as extensive metabolizers (EM) or poor metabolizers (PM).
    • Poor sparteine metabolism was confirmed to be inherited as an autosomal recessive trait across 20 pedigrees.
    • Lower dehydrosparteine recovery was observed in heterozygotes compared to unrelated EM.

    Conclusions:

    • The study confirms the autosomal recessive inheritance of sparteine poor metabolism.
    • This genetic polymorphism significantly impacts drug oxidation pathways.
    • Further research into pharmacogenetic variations can optimize drug therapy.

    Related Experiment Videos